BPGAM
EW icon

BTG Pactual Global Asset Management’s Edwards Lifesciences EW Stock Holding History

BTG Pactual Global Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-24,120
Closed -$573K – 198
2015
Q1 		$573K Buy
24,120
+6,120
+34% +$137K 0.04% 139
2014
Q4 		$382K Buy
+18,000
New +$362K 0.03% 130

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BTG Pactual Global Asset Management's EW Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of Edwards Lifesciences (EW) in Q2 2015, closing a stake of 24,120 shares — an estimated $573K sold.

BTG Pactual Global Asset Management first reported a position in EW in Q4 2014 and held it in 2 quarters. The position peaked at $573K in Q1 2015. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

  • BTG Pactual Global Asset Management reported no remaining Edwards Lifesciences position as of Q2 2015 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 24,120 Edwards Lifesciences shares in Q2 2015, an estimated $573K.
  • BTG Pactual Global Asset Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 2 quarters.
  • BTG Pactual Global Asset Management's Edwards Lifesciences position peaked at $573K in Q1 2015.
  • 579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.